Datametrex Obtains Rights to Import and Sell COVID-19 Test Kits From South Korea
April 16 2020 - 4:00AM
Datametrex AI Limited (the
“
Company” or “
Datametrex”) is
pleased to announce that entered into an agreement on April 13,
2020 securing the rights to import the iONEBIO INC’s iLAMP
Novel-CoV19 Detection Kit (real-time Reverse Transcription LAMP-PCR
assay system) into Canada, Under the terms of this agreement,
Datametrex was also given rights to sell the tests into other
countries around the globe, including the United States. Datametrex
has developed strong relationships with many large multi-national
companies in South Korea. As a result of these relationships,
the Canadian Embassy in Seoul contacted Datametrex to ask for help
in procuring rapid test kits.
The COVID-19 test kits are manufactured by
iONEBIO INC. in South Korea, and are the same test kits that have
been successfully used in South Korea in their “drive-through”
testing stations. This kit has also been used to test every
traveller entering into South Korea and those testing positive for
Covid-19 were immediately isolated. Datametrex believes a key
factor that allowed South Korea to slow the spread of COVID-19 was
its ability to swiftly identify and quarantine those infected by
testing millions of people using these test kits These test
kits were first approved for use by the Korean Ministry of Food and
Drug Safety on August 30, 2019. In addition, an independent
study was conducted by DankukUniversity (DKU) in Seoul, South
Korea, and it was completed and approved on April 2, 2020.
Health Canada must approve these COVID-19 test
kits before they can be used in Canada. The Company is currently
working with Health Canada to have the approval of these kits fast
tracked. These test kits are currently in use in some
European and Asian countries outside of South Korea. Approval work
has commenced with the FDA in the United States to obtain FDA
approval and to authorize the tests under the Emergency Use
Authorization Program run by US Center for Disease Control
(CDC).
iONEBIO Inc. claims their test kits provide
results within approximately 15 to 20 minutes with 99.9% accuracy.
Each kit contains 288 individual tests, all of which can be
completed in one hour. By utilizing these kits, screening stations
can be set up almost anywhere and will allow for the early
detection and swift quarantine of infected persons, which is
believed to be a key factor in slowing the spread of the novel
coronavirus. Early detection using rapid tests will also
provide further protection to Canada’s front-line workers,
especially health care professionals.
South Korea has used this kit to test millions
of its citizens and, as of April 14, 2020, there have been 10,654
cases of Covid-19 and 222 deaths reported. In North America, where
the use of a rapid test has not been implemented on a large scale,
there have been, as at April 14, 2020, 25,680 cases and 780 deaths
in Canada and 588,465 cases and 23,711 death in the US. (All
data collected by Datametrex’s Covid-19 dashboard, which is
available at http://www.datametrex.com/covid-board.html)
“We strongly believe these kits will assist
Canada in slowing the spread of Covid-19 and ultimately save lives.
It’s incredibly rewarding for us to be able to help Canada combat
the spread of COVID-19,” said Andrew Ryu, Chairman of the
Company.
If the test kits are approved by Health Canada
and the Canadian government purchases these test kits as expected,
the Canadian government will be required to pay the kits in
advance. Datametrex expects that all of its costs and expenses
related to the import of these tests will be satisfied out of the
purchase price for the tests paid for by the Canadian
government.
The Company is not making any express or
implied claims that it has the ability to treat the Covid-19 virus
at this time.
About Datametrex AI Limited
Datametrex AI Limited is a technology-focused
company with exposure to Artificial Intelligence and Machine
Learning through its wholly-owned subsidiary, Nexalogy
(www.nexalogy.com).Additional information on Datametrex is
available at www.datametrex.com
For further information, please
contact:
Marshall Gunter – CEOPhone: (514) 295-2300Email:
mgunter@datametrex.com
Jeff Stevens- Co-FounderPhone: (647)
400-8494Email: jstevens@datametrex.com
Neither the TSX Venture Exchange nor it's
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains "forward-looking
information" within the meaning of applicable securities
laws. All statements contained herein that are not clearly
historical in nature may constitute forward-looking information. In
some cases, forward-looking information can be identified by words
or phrases such as "may", "will", "expect", "likely", "should",
"would", "plan", "anticipate", "intend", "potential", "proposed",
"estimate", "believe" or the negative of these terms, or other
similar words, expressions and grammatical variations thereof, or
statements that certain events or conditions "may" or "will"
happen, or by discussions of strategy.
Readers are cautioned to consider these and
other factors, uncertainties and potential events carefully and not
to put undue reliance on forward-looking information. The
forward-looking information contained herein is made as of the date
of this press release and is based on the beliefs, estimates,
expectations, and opinions of management on the date such
forward-looking information is made. The Company undertakes no
obligation to update or revise any forward-looking information,
whether as a result of new information, estimates or opinions,
future events or results or otherwise or to explain any material
difference between subsequent actual events and such
forward-looking information, except as required by applicable
law.
DataMetrex AI (TSXV:DM)
Historical Stock Chart
From Sep 2024 to Oct 2024
DataMetrex AI (TSXV:DM)
Historical Stock Chart
From Oct 2023 to Oct 2024